These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2348445)

  • 21. Tumor antigen markers for the detection of solid cancers in inflammatory myopathies.
    Amoura Z; Duhaut P; Huong DL; Wechsler B; Costedoat-Chalumeau N; Francès C; Cacoub P; Papo T; Cormont S; Touitou Y; Grenier P; Valeyre D; Piette JC
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1279-82. PubMed ID: 15894686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dermatomyositis and polymyositis. Review of 17 cases].
    Martín Mola E; Mateo Bernardo I; Gijón Baños J; Postigo Alvarez JL; Muñoz Blanch R; Fernandez del Vallado P
    Rev Clin Esp; 1980 Nov; 159(4):251-5. PubMed ID: 7221088
    [No Abstract]   [Full Text] [Related]  

  • 23. [Coexistence of hypothyroidism with polymyositis or dermatomyositis].
    Lukjanowicz M; Bobrowska-Snarska D; Brzosko M
    Ann Acad Med Stetin; 2006; 52 Suppl 2():49-55. PubMed ID: 17471837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methylprednisolone pulse therapy in active polymyositis/dermatomyositis].
    Hrncír Z; Bradna P; Pidrman V; Tichý M
    Vnitr Lek; 1988 Apr; 34(4):376-83. PubMed ID: 3394263
    [No Abstract]   [Full Text] [Related]  

  • 25. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis.
    Grundtman C; Tham E; Ulfgren AK; Lundberg IE
    Arthritis Rheum; 2008 Oct; 58(10):3224-38. PubMed ID: 18821695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [On some clinico-pathogenetic aspects of polymyositis and dermatomyositis].
    Turinese A; Pagnes P
    G Psichiatr Neuropatol; 1966; 94(1):191-213. PubMed ID: 5947387
    [No Abstract]   [Full Text] [Related]  

  • 27. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
    Adams EM; Pucino F; Yarboro C; Hicks JE; Thornton B; McGarvey C; Sonies BC; Bartlett ML; Villalba ML; Fleisher T; Plotz PH
    J Rheumatol; 1999 Feb; 26(2):352-60. PubMed ID: 9972969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinicopathological studies on interstitial lung disease in polymyositis-dermatomyositis].
    Takizawa H; Hidaka N; Akiyama K; Hisatomi T; Kosuda T; Ishimitsu T; Miyachi S; Nishiwaki M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 May; 23(5):528-36. PubMed ID: 4057702
    [No Abstract]   [Full Text] [Related]  

  • 29. [Epidemiology of connective tissue diseases of the skin (scleroderma, dermatomyositis and polymyositis) in Japan].
    Hatano H
    Hautarzt; 1982 Jul; 33(7):355-8. PubMed ID: 7107279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and electromyographic studies on polymyositis-dermatomyositis].
    Tang XF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Jun; 19(3):132-5. PubMed ID: 3757624
    [No Abstract]   [Full Text] [Related]  

  • 31. Dermatomyositis sine myositis: association with malignancy.
    Whitmore SE; Watson R; Rosenshein NB; Provost TT
    J Rheumatol; 1996 Jan; 23(1):101-5. PubMed ID: 8838516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory myopathies [polymyositis, dermatomyositis, inclusion body myositis].
    Bertorini TE
    Compr Ther; 1998 Oct; 24(10):494-502. PubMed ID: 9801848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated myositis: clinical features and prognostic signs.
    Ponyi A; Constantin T; Garami M; András C; Tállai B; Váncsa A; Gergely L; Dankó K
    Ann N Y Acad Sci; 2005 Jun; 1051():64-71. PubMed ID: 16126945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory myopathies--a clinicopathologic study.
    Radhakrishnan VV; Nair MD; Kuruvilla A; Radhakrishnan K
    Indian J Pathol Microbiol; 1997 Jul; 40(3):315-20. PubMed ID: 9354000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of the myositis activities profile--validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis.
    Alexanderson H; Lundberg IE; Stenström CH
    J Rheumatol; 2002 Nov; 29(11):2386-92. PubMed ID: 12415597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renal manifestations in dermatomyositis and polymyositis].
    Pasquali JL; Meyer P; Christmann D; Picard A; Grosshans E; Storck D
    Ann Med Interne (Paris); 1987; 138(2):109-13. PubMed ID: 3579091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Polymyositis and dermatomyositis in the metropolitan hospital complex of the Panama Department of Social Security. 1973. Clinical review and effects of treatment].
    Achurra Castillo AF; Bulgín O; López RI; Benítez R; Llerena JM; Villarreal V; Sandoval E
    Rev Med Panama; 1985 Jan; 10(1):1-14. PubMed ID: 3969498
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preneoplastic dermatomyositis and polymyositis].
    Novák Z; Biskupová H; Matznerová S; Vachtenheim J
    Fysiatr Revmatol Vestn; 1980 Jan; 58(1):41-6. PubMed ID: 7188922
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis.
    Dastmalchi M; Alexanderson H; Loell I; Ståhlberg M; Borg K; Lundberg IE; Esbjörnsson M
    Arthritis Rheum; 2007 Oct; 57(7):1303-10. PubMed ID: 17907213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.